A Phase II Study Evaluating the Efficacy and Safety of Pembrolizumab in Combination With Chemotherapy as Neoadjuvant Therapy for Triple-negative Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Pembrolizumab|DRUG: Paclitaxel|DRUG: Epirubicin|DRUG: Cyclophosphamide
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences